re: Ann: Sirtex Completes SIRFLOX Patient Rec... "Important to correct you cafa. The FDA does not currently stipulate at what line of treatment sir-spheres should be used. A US physician is allowed to use them at any line of treatment. It won't matter a jot if FDA doesn't change the labeling in any way. The result of this study is only designed to convince oncologists to refer patients and to get sir-spheres into medical practice guidelines that dictate what physicians treat with."
I dispute this assertion, based on the posts I published. Unless you are suggesting that SRX will obtain a step wise increase in sales as off-label usage???
The PMA makes it very clear the conditions under which SRX may market in the US. Maybe my understanding of FDA regulations is wrong. Happy to be correct based on some evidence.
- Forums
- ASX - By Stock
- Ann: Sirtex Completes SIRFLOX Patient Recruitment
re: Ann: Sirtex Completes SIRFLOX Patient Rec... "Important to...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
(20min delay)
|
|||||
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $75.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
SRX (ASX) Chart |
Day chart unavailable
The Watchlist
TON
TRITON MINERALS LTD
Adrian Costello, Executive Director
Adrian Costello
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online